Claes Wahlestedt

Claes Wahlestedt" alt="Claes Wahlestedt" itemprop="image">

Company: University of Miami Miller School of Medicine; Epigenetix

Job title: Associate Dean & Center Director for Therapeutic Innovation; Chief Scientific Officer


PANEL DISCUSSION: Let’s Talk About Epigenetic Drug Resistance 2:00 pm

Exploring the ways in which drug resistance develops in relation to epigenetics Considering epigenetic mechanisms implicit in drug resistance Combating drug resistance with epigenetic drugs in combinational therapiesRead more

day: Day Two

Exploring the Discovery & Development of an Oral Trispecific Cancer Drug 11:45 am

Developing new understanding of existing targets and their functions Acquiring awareness of novel targets and the potential for new inhibitor development Combining multiple cancer fighting properties in one drug and advancing clinical biomarker utility in the epigenetic spaceRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.